AMPD1: a novel therapeutic target for reversing insulin resistance

Inhibition of AMP Deaminase Activity Does Not Improve Glucose Control in Rodent Models of Insulin Resistance or Diabetes

(2014) Therese Admyre et al.   CHEMISTRY & BIOLOGY

Effects of Pharmacological AMP Deaminase Inhibition and Ampd1 Deletion on Nucleotide Levels and AMPK Activation in Contracting Skeletal Muscle

(2014) Catheline Plaideau et al.   CHEMISTRY & BIOLOGY

AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer

(2013) D. G. Hardie   DIABETES

Fatty acid metabolism, energy expenditure and insulin resistance in muscle

(2013) Nigel Turner et al.   JOURNAL OF ENDOCRINOLOGY

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

(2013) Steven E Kahn et al.   LANCET

AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases

(2010) Krzysztof Safranow et al.   JOURNAL OF APPLIED GENETICS

Metformin Activates AMP Kinase through Inhibition of AMP Deaminase

(2010) Jiangyong Ouyang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Association of C34TAMPD1gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure

(2008) Krzysztof Safranow et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION